Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.390
+0.040 (1.70%)
At close: Apr 28, 2026, 4:00 PM EDT
2.430
+0.040 (1.67%)
After-hours: Apr 28, 2026, 7:10 PM EDT
Alector Market Cap
Alector has a market cap or net worth of $263.77 million as of April 28, 2026. Its market cap has increased by 194.37% in one year.
Market Cap
263.77M
Enterprise Value
45.08M
1-Year Change
194.37%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since February 7, 2019, Alector's market cap has decreased from $1.23B to $263.77M, a decrease of -78.57%. That is a compound annual growth rate of -19.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 259.35M | 52.31% |
| Dec 31, 2025 | 170.28M | -8.00% |
| Dec 31, 2024 | 185.09M | -72.43% |
| Dec 29, 2023 | 671.41M | -12.04% |
| Dec 30, 2022 | 763.34M | -54.52% |
| Dec 31, 2021 | 1.68B | 39.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Editas Medicine | 284.81M |
| NovaBridge Biosciences | 283.34M |
| Zentalis Pharmaceuticals | 282.31M |
| AC Immune | 281.73M |
| C4 Therapeutics | 281.03M |
| Cellectis | 280.95M |
| Cybin | 280.70M |
| Protara Therapeutics | 277.45M |